Le laboratoire est détenteur de 3 brevets :

Le Garrec R, L’herondelle K, Misery L, Pierre O, Mignen O (2019) Protease-activated receptor-2 inhibitors for the treatment of sensory neuropathy induced by a marine neurotoxin poisoning. EP19 305 453.3

Ben-Ari Y, Lemonnier E (2010) Compounds for the treatment of autism PCT/EP2011/050394

Ben-Ari Y, Lemonnier E, Burnashev N, Tyzio R (2012) Modulators of intracellular chloride concentration for treating fragile X syndrome: PCT/EP2013/073942